I am a 47-year-old woman who lost 72 pounds on Wegovy over 10 months. From 223 to 151 pounds. By every metabolic marker, I am healthier than I have been in 20 years. But I need to talk about what happened to my face.
Around month 4, at about 40 pounds lost, I started noticing that I looked older in photos. Not just thinner — older. The fat pads in my cheeks, which I had always taken for granted, were disappearing. My nasolabial folds (the lines from nose to mouth) deepened significantly. The hollows under my eyes became more pronounced. My jawline, while more defined, was bordered by skin that no longer had enough volume underneath to stay taut.
By month 8, people started commenting. Not compliments on my weight loss. Questions about whether I was feeling okay. Whether I had been ill. My mother told me I looked "gaunt." I am 47 — I do not have the skin elasticity of a 25-year-old, and rapid fat loss at my age means the skin has nowhere to go.
I consulted a dermatologist who confirmed that rapid facial volume loss is the driver. She said that at my age and rate of loss, some degree of this was inevitable. She recommended dermal fillers for the mid-face hollowing — which is effective but costs thousands and needs maintenance every 12-18 months.
I am still on Wegovy because the health benefits outweigh the cosmetic concerns. But I wish someone had been honest with me upfront about this tradeoff, particularly for women over 40. Slower weight loss might have given my skin more time to adjust. Starting retinoids and collagen supplementation earlier might have helped marginally. But "Ozempic face" is a real phenomenon and it disproportionately affects people who lose large amounts of weight quickly in middle age.
The Reddit communities discuss this, but it is often brushed aside with "you look great, do not worry about it." That is kind but not helpful. If you are starting a GLP-1 agonist and you are over 40, take facial photos monthly, consider prophylactic skincare, discuss the rate of weight loss with your prescriber, and have realistic expectations about the cosmetic outcome alongside the metabolic one.